Phase 2CompletedINTERVENTIONAL
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov · NCT00028769 · Registry updated: 2013-07-16
- Condition / research focus
- Prostate Cancer
- Sponsor
- SWOG Cancer Research Network
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2001-12. Completion: 2011-07 (may be estimated). Results are posted in this registry.
Products and interventions (8)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- bicalutamide (drug)
- estramustine (drug) — also listed as: estramustine phosphate sodium
- etoposide (drug)
- flutamide (drug)
- goserelin (drug)
- leuprolide (drug) — also listed as: leuprolide acetate
- nilutamide (drug)
- paclitaxel (drug)
Where the study takes place — 91 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.